about
Upper extremity 3-dimensional reachable workspace analysis in dystrophinopathy using KinectDevelopment and application of stereo camera-based upper extremity workspace evaluation in patients with neuromuscular diseasesChronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophyChronic pain in persons with neuromuscular disease.Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by KinectAtaluren treatment of patients with nonsense mutation dystrophinopathy.The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.Measuring quality of life in muscular dystrophy.Reachable workspace reflects dynamometer-measured upper extremity strength in facioscapulohumeral muscular dystrophy.Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular DystrophyReachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy.Pain in persons with postpolio syndrome: frequency, intensity, and impact.New clinical end points in rehabilitation medicine: tools for measuring quality of life.Aging with muscular dystrophy: pathophysiology and clinical management.Regional and whole-body dual-energy X-ray absorptiometry to guide treatment and monitor disease progression in neuromuscular disease.Body composition and water compartment measurements in boys with Duchenne muscular dystrophy.Upper extremity reachable workspace evaluation with Kinect.Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength.The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD).Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease.The reliability and validity of a self-report version of the FIM instrument in persons with neuromuscular disease and chronic pain.Pain in Myotonic Muscular Dystrophy, Type 1
P50
Q27332140-891CAE8E-31F4-458D-AA22-9AE0B34353C6Q30463297-65C3A464-2B75-48EC-81C0-4F27151D8C7DQ33689720-3B121A22-FC89-42FD-9DBA-8D3E677FE147Q33752517-5208F292-5987-4065-ABB1-DFF9C4BA000CQ33987789-F844F447-DF98-4E90-87BF-755F0BE54070Q34151082-11874A90-999A-4720-9D45-87E98604CFD3Q34517198-695626A1-33AB-4398-BB34-03808AD19FCEQ34561960-02E98F62-8B9E-44A8-B2F4-114D109C3FC3Q34836557-74C38BDB-E671-4734-9C93-DF47D831E94FQ35154897-1DF3D0A7-4ADA-4281-A858-278A8526FCA6Q36073192-B95F2241-9A29-44A5-9890-E7D7577C6453Q36287980-AF5383E6-A5DD-4E68-B65E-4048CA5FF2D7Q36654988-6DEA6CC8-F306-4D72-8BAE-2C794E58365BQ37118259-334EA0BB-8FE5-4C4E-A757-967C85A7A4DEQ37634844-1793673D-1A76-4563-90FD-42D029678E93Q37759850-8E45ADE4-F9FB-48F9-930F-C78BBA954848Q37975314-69562EA1-80EF-421C-87CD-B38FFE9567C8Q43877953-CECA479C-A7B4-4788-8641-6D86FA7F30E7Q44463237-36008BA4-5AD8-49F6-80FD-90AA7148673CQ45935564-B2CC8940-91B6-4140-812C-934D508BE9C8Q46125771-5C2262DC-F934-423E-91FC-6BC44494D6B0Q46211545-B7F2AFE1-E11C-4E01-B1BC-FDA963E8EAD3Q46466043-94323378-69BF-4B6D-A3E1-44A69688A21CQ51556414-2AEA9C58-E436-4C06-B674-7BF7D88C8C97Q59876231-F0BF6806-7891-495E-BF5C-18FD26BAE34C
P50
name
Richard T Abresch
@en
type
label
Richard T Abresch
@en
prefLabel
Richard T Abresch
@en